- ►annals.org [PDF] K Malmstrom, G Rodriguez-Gomez, J Guerra, C … - Annals of internal medicine, 1999 - Am Coll Physicians Kerstin Malmstrom, PhD; Guillermo Rodriguez-Gomez, MD; Jeremias Guerra, MD;
Cesar Villaran, MD; Andres Pin˜eiro, MD; Lynn X. Wei, PhD; Beth C. Seidenberg,
MD; and Theodore F. Reiss, MD, for the Montelukast/Beclomethasone Study Group* Cited by 385 - Related articles - BL Direct - All 4 versions
К Мальстром, Г Родригес-Гомес, Х Гуэрра, … - mediasphera.ru Translated, with permission of ACP—ASIM, from: K. Malstrom, G.
Rodriguez-Gomez, J. Guerra, C. Villaran, A. Pineiro, LX Wei, BC Seidenberg, TF
Reiss, for the Montelukast/Beclomethasone Study Group. Oral montelukast, ... Related articles
TF Reiss, P Chervinsky, RJ Dockhorn, S … - Archives of Internal Medicine, 1998 - archinte.highwire.org You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Add to CiteULike Add to ... Cited by 330 - Related articles - BL Direct - All 5 versions
- ►171.66.122.149 M Laviolette, K Malmstrom, S Lu, P Chervinsky … - American journal of respiratory and critical care …, 1999 - 171.66.122.149 The primary objective of this study was to determine whether montelukast, an
oral leukotriene receptor antagonist, provides additional clinical benefit to
the effect of inhaled corticosteroids. A total of 642 patients with chronic ... Cited by 265 - Related articles - BL Direct - All 6 versions
- ►bmj.com CG Lofdahl, TF Reiss, JA Leff, E Israel, MJ … - British Medical Journal, 1999 - bmj.com You are seeing this message because your web browser does not support basic web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Claes-Göran Löfdahl , ... Cited by 222 - Related articles - BL Direct - All 8 versions
B Knorr, J Matz, JA Bernstein, H Nguyen, BC … - Jama, 1998 - Am Med Assoc Context.— Leukotrienes are important mediators of asthma by causing
bronchoconstriction, mucous secretion, and increased vascular permeability.
Studies using compounds that block leukotrienes have demonstrated ... Cited by 411 - Related articles - BL Direct - All 3 versions
SJ Szefler, RJ Martin, TS King, HA Boushey, … - The Journal of Allergy and Clinical Immunology, 2002 - Elsevier From the National Jewish Medical and Research Center, Denver (RMC, MK, RJM,
SJS); Brigham and Women's Hospital and Harvard Medical School, Boston (JD, EI);
Harlem Hospital Center and Columbia University, New York City (JGF, JF); ... Cited by 255 - Related articles - BL Direct - All 3 versions
ER Bleecker, MJ Welch, SF Weinstein, C … - Journal of Allergy and Clinical Immunology, 2000 - Elsevier In this study the efficacy and safety of the lowest recommended dose (88 μg
twice daily [BID]) of the inhaled corticosteroid fluticasone propionate (FP) was
compared with that of the recommended dose of oral zafirlukast (20 mg BID). ... Cited by 94 - Related articles - BL Direct - All 7 versions
JA Leff, WW Busse, D Pearlman, EA Bronsky, … - The New England journal of medicine, 1998 - nejm.highwire.org Methods We randomly assigned 110 patients (age, 15 to 45 years) with mild asthma
and a decrease in the forced expiratory volume in one second (FEV 1 ) of at
least 20 percent after exercise on two occasions during a placebo run-in ... Cited by 402 - Related articles - BL Direct - All 6 versions
